- In 2018, the FDA granted breakthrough designation to the MI assay in DISCERN and FDA review is pending.
- DISCERN test is covered by and paid for by Medicare Fee-for Service.
- DISCERN test has been awarded two unique CPT (PLA) codes 206U (MI & PKC) diagnostic tests and 207U (AD index) confirmatory test.
|2022 Medicare Fee For Service payments|
Input your search keywords and press Enter.